843 related articles for article (PubMed ID: 14729589)
61. Epigenetic regulation of multidrug resistance 1 gene expression: profiling CpG methylation status using bisulphite sequencing.
Baker EK; El-Osta A
Methods Mol Biol; 2010; 596():183-98. PubMed ID: 19949925
[TBL] [Abstract][Full Text] [Related]
62. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors.
Stirzaker C; Millar DS; Paul CL; Warnecke PM; Harrison J; Vincent PC; Frommer M; Clark SJ
Cancer Res; 1997 Jun; 57(11):2229-37. PubMed ID: 9187126
[TBL] [Abstract][Full Text] [Related]
63. The role of DNA methylation in setting up chromatin structure during development.
Hashimshony T; Zhang J; Keshet I; Bustin M; Cedar H
Nat Genet; 2003 Jun; 34(2):187-92. PubMed ID: 12740577
[TBL] [Abstract][Full Text] [Related]
64. Methylation of promoter region in p27 gene plays a role in the development of lymphoid malignancies.
Nakatsuka S; Liu A; Yao M; Takakuwa T; Tomita Y; Hoshida Y; Nishiu M; Aozasa K
Int J Oncol; 2003 Mar; 22(3):561-8. PubMed ID: 12579309
[TBL] [Abstract][Full Text] [Related]
65. Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island.
Simpson DJ; Hibberts NA; McNicol AM; Clayton RN; Farrell WE
Cancer Res; 2000 Mar; 60(5):1211-6. PubMed ID: 10728677
[TBL] [Abstract][Full Text] [Related]
66. Expression of the human Sd(a) beta-1,4-N-acetylgalactosaminyltransferase II gene is dependent on the promoter methylation status.
Wang HR; Hsieh CY; Twu YC; Yu LC
Glycobiology; 2008 Jan; 18(1):104-13. PubMed ID: 17965433
[TBL] [Abstract][Full Text] [Related]
67. Epigenetic changes in the DAP-kinase CpG island in pediatric lymphoma.
Shiramizu B; Mick P
Med Pediatr Oncol; 2003 Dec; 41(6):527-31. PubMed ID: 14595709
[TBL] [Abstract][Full Text] [Related]
68. Methylation of the human telomerase gene CpG island.
Dessain SK; Yu H; Reddel RR; Beijersbergen RL; Weinberg RA
Cancer Res; 2000 Feb; 60(3):537-41. PubMed ID: 10676632
[TBL] [Abstract][Full Text] [Related]
69. Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer.
Lee PS; Teaberry VS; Bland AE; Huang Z; Whitaker RS; Baba T; Fujii S; Secord AA; Berchuck A; Murphy SK
Int J Cancer; 2010 Mar; 126(6):1378-89. PubMed ID: 19642140
[TBL] [Abstract][Full Text] [Related]
70. Correlation of COL10A1 induction during chondrogenesis of mesenchymal stem cells with demethylation of two CpG sites in the COL10A1 promoter.
Zimmermann P; Boeuf S; Dickhut A; Boehmer S; Olek S; Richter W
Arthritis Rheum; 2008 Sep; 58(9):2743-53. PubMed ID: 18759285
[TBL] [Abstract][Full Text] [Related]
71. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.
Costello JF; Frühwald MC; Smiraglia DJ; Rush LJ; Robertson GP; Gao X; Wright FA; Feramisco JD; Peltomäki P; Lang JC; Schuller DE; Yu L; Bloomfield CD; Caligiuri MA; Yates A; Nishikawa R; Su Huang H; Petrelli NJ; Zhang X; O'Dorisio MS; Held WA; Cavenee WK; Plass C
Nat Genet; 2000 Feb; 24(2):132-8. PubMed ID: 10655057
[TBL] [Abstract][Full Text] [Related]
72. General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells.
Gebhard C; Benner C; Ehrich M; Schwarzfischer L; Schilling E; Klug M; Dietmaier W; Thiede C; Holler E; Andreesen R; Rehli M
Cancer Res; 2010 Feb; 70(4):1398-407. PubMed ID: 20145141
[TBL] [Abstract][Full Text] [Related]
73. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.
Chen Y; Gao W; Luo J; Tian R; Sun H; Zou S
Oncol Rep; 2011 Feb; 25(2):443-51. PubMed ID: 21165562
[TBL] [Abstract][Full Text] [Related]
74. Reduced CpG methylation is associated with transcriptional activation of the bone-specific rat osteocalcin gene in osteoblasts.
Villagra A; Gutiérrez J; Paredes R; Sierra J; Puchi M; Imschenetzky M; Wijnen Av Av; Lian J; Stein G; Stein J; Montecino M
J Cell Biochem; 2002; 85(1):112-22. PubMed ID: 11891855
[TBL] [Abstract][Full Text] [Related]
75. Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture.
Stimson KM; Vertino PM
J Biol Chem; 2002 Feb; 277(7):4951-8. PubMed ID: 11733524
[TBL] [Abstract][Full Text] [Related]
76. The tumor suppressor gene 14-3-3 sigma is commonly methylated in normal and malignant lymphoid cells.
Bhatia K; Siraj AK; Hussain A; Bu R; Gutiérrez MI
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):165-9. PubMed ID: 12582028
[TBL] [Abstract][Full Text] [Related]
77. Epigenetic inactivation of MCJ (DNAJD1) in malignant paediatric brain tumours.
Lindsey JC; Lusher ME; Strathdee G; Brown R; Gilbertson RJ; Bailey S; Ellison DW; Clifford SC
Int J Cancer; 2006 Jan; 118(2):346-52. PubMed ID: 16049974
[TBL] [Abstract][Full Text] [Related]
78. Extensive methylation of a part of the CpG island located 3.0-4.5 kbp upstream to the chicken alpha-globin gene cluster may contribute to silencing the globin genes in non-erythroid cells.
Razin SV; Ioudinkova ES; Scherrer K
J Mol Biol; 2000 Jun; 299(4):845-52. PubMed ID: 10843840
[TBL] [Abstract][Full Text] [Related]
79. Epigenetic patterns at the mouse prolyl oligopeptidase gene locus suggest the CpG island in the gene body to be a novel regulator for gene expression.
Matsubara S; Takahashi T; Kimura AP
Gene; 2010 Oct; 465(1-2):17-29. PubMed ID: 20600704
[TBL] [Abstract][Full Text] [Related]
80. Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors.
Lapidus RG; Ferguson AT; Ottaviano YL; Parl FF; Smith HS; Weitzman SA; Baylin SB; Issa JP; Davidson NE
Clin Cancer Res; 1996 May; 2(5):805-10. PubMed ID: 9816234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
